Primary care; Hip; Knee; Hand; Consensus; Care pathways; Diagnosis; General Practitioners; Specialist intervention tresholds
Abstract :
[en] Background and aims: Although osteoarthritis (OA) is managed mainly in primary care, general practitioners (GPs) are not always trained in its diagnosis, which leads to diagnostic delays, unnecessary resource utilization, and suboptimal patient outcomes.
Methods: To address this situation, an International Rheumatologic Board (IRB) of 8 experts from 3 continents developed guidelines for the diagnosis of OA in primary care. The focus was three major topologies: hip, knee, and hand/finger OA. The IRB used American College of Rheumatology diagnostic criteria.
Results: Care pathways based on clinical and radiological findings were developed to identify intervention thresholds for GPs/specialists. To optimize usefulness in the primary care setting, the guidelines were formatted as an uncomplicated, but comprehensive one-page decision tree for each topology, highlighting key aspects of the evaluation process and incorporating
red flags. In a two-phase validation stage, the draft guidelines were evaluated by rheumatologists and GPs for project execution, content and perceived benefit. The strength of the guidelines lies in their user-friendly diagram and potential for broad application. Such guidelines will allow GPs to make an easy but definite diagnosis of OA and offer clear guidance
about situations requiring an expert opinion. The guidelines have potential to improve patient outcomes and reduce the number of unnecessary procedures.
Discussion and conclusions: This project demonstrated the feasibility of developing easy-to-use and effective visual decision trees to facilitate the diagnosis and management of OA of the hip, knee and hand/finger in primary care. The next step should be to conduct a large impact study of implementation of these recommendations in the diagnostic management of OA in general practice in different areas.
Disciplines :
General & internal medicine
Author, co-author :
Martel-Pelletier, J.
Maheu, E.
Pelletier, J.P.
Alekseeva, L.
Mkinsi, O.
Branco, J.
Monod, P.
Planta, F
Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Rannou, F.
Language :
English
Title :
A new decision tree for diagnosis and management of osteoarthritis in primary care: international consensus of experts.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Vos T, Flaxman AD, Naghavi M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196
Cross M, Smith E, Hoy D et al (2014) The global burden of hip and knee OA: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014 73:1323–1330
Allen KD, Choong PF, Davis AM et al (2016) OA: Models for appropriate care across the disease continuum. Best Pract Res Clin Rheumatol 30:503–535
Litwic A, Edwards MH, Dennison EM, Cooper C (2013) Epidemiology and burden of OA. Br Med Bull 105:185–199
Loeser RF, Goldring SR, Scanzello CR, Goldring MB (2012) OA: a disease of the joint as an organ. Arthritis Rheum 64:1697–1707
Loeser RF, Collins JA, Diekman BO (2016) Ageing and the pathogenesis of OA. Nat Rev Rheumatol 12:412–420
Wittenauer R, Smith L, Aden K (2013) Update on 2004 Background paper, BP 6.12 OA. In: Kaplan W, Wirtz VJ, Mantel-Teeuwisse A, Stolk P, Duthey B, Laing R (eds) Priority medicines for Europe and the world—2013 update. World Health Organization, Geneva
Bertin P, Rannou F, Grange L et al (2014) Annual cost of patients with OA of the hip and knee in France. J Musculoskelet Pain 22:356–364
Nur H, Sertkaya BS, Tuncer T (2018) Determinants of physical functioning in women with knee OA. Aging Clin Exp Res 30:299–306
Beaudart C, Biver E, Bruyère O et al (2018) Quality of Life assessment in musculo-skeletal health. Aging Clin Exp Res 30:413–418
Duffield SJ, Ellis BM, Goodson N et al (2017) The contribution of musculoskeletal disorders in multimorbidity: implications for practice and policy. Best Pract Res Clin Rheumatol 31:129–144
Nüesch E, Dieppe P, Reichenbach S, Williams S, Iff S, Jüni P (2011) All cause and disease specific mortality in patients with knee or hip OA: population based cohort study. BMJ 342:d1165
Kasai T, Hasegawa Y, Imagama S et al (2017) The impact of musculoskeletal diseases on mortality-comparison with internal diseases: a 15-year longitudinal study. J Orthop Sci 22:1126–1131
Bruyere O, Cooper C, Pelletier JP et al (2014) An algorithm recommendation for the management of knee OA in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and OA (ESCEO). Semin Arthritis Rheum 44:253–263
Marcum ZA, Perera S, Donohue JM et al (2011) Analgesic use for knee and hip OA in community-dwelling elders. Pain Med (Malden Mass) 12:1628–1636
Richardson CG, Chalmers A, Llewellyn-Thomas HA, Klinkhoff A, Carswell A, Kopec JA (2007) Pain relief in OA: patients’ willingness to risk medication-induced gastrointestinal, cardiovascular, and cerebrovascular complications. J Rheumatol 34:1569–1575
Healey EL, Afolabi EK, Lewis L et al (2014) Uptake of the NICE OA core treatments in community dwelling older adults with a self-reported primary care consultation for joint pain. Rheumatology 53:i83
Paskins Z, Sanders T, Hassell AB (2014) Comparison of patient experiences of the OA consultation with GP attitudes and beliefs to OA: a narrative review. BMC Fam Pract 19:46
Egerton T, Diamond LE, Buchbinder R, Bennell KL, Slade SC (2017) A systematic review and evidence synthesis of qualitative studies to identify primary care clinicians’ barriers and enablers to the management of OA. Osteoarthr Cartil 25:625–638
Tzortziou Brown V, Underwood M, Mohamed N, Westwood O, Morrissey D (2016) Professional interventions for general practitioners on the management of musculoskeletal conditions. Cochrane Database Syst Rev 6:CD007495
Loyola-Sanchez A, Richardson J, Pelaez-Ballestas I et al (2014) Barriers to implementing the “2008 Mexican Clinical Practice Guideline recommendations for the management of hip and knee OA” in primary healthcare practice. Reumatol Clin 10:364–372
Ferreira de Meneses S, Rannou F, Hunter DJ (2016) OA guidelines: barriers to implementation and solutions. Ann Phys Rehabil Med 59:170–173
Basedow M, Runciman WB, Lipworth W, Esterman A (2016) Australian general practitioner attitudes to clinical practice guidelines and some implications for translating OA care into practice. Aust J Prim Health 22:403–408
Altman R, Asch E, Bloch D et al (1986) Development of criteria for the classification and reporting of OA. Classification of OA of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049
Parsons C, Fuggle NR, Edwards MH et al (2018) Concordance between clinical and radiographic evaluations of knee OA. Aging Clin Exp Res 30:17–25
Brown GA (2013) AAOS clinical practice guideline: treatment of OA of the knee: evidence-based guideline, 2nd edn. J Am Acad Orthop Surg 21:577–579
Hochberg MC, Altman RD, April KT et al (2012) American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in OA of the hand, hip, and knee. Arthritis Care Res (Hoboken) 64:465–474
Chinese Orthopedic Association (2010) Diagnosis and treatment of OA. Orthop Surg 2:1–6
Zhang W, Doherty M, Leeb BF et al (2007) EULAR evidence based recommendations for the management of hand OA—report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66:377–388
Jordan KM, Arden NK, Doherty M et al (2003) Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee OA: report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62:1145–1155
National Institute for Health and Care Excellence. OA: care and management (2014) Available at: https://www.nice.org.uk/guidance/cg177/resources/OA-care-and-management-35109757272517
McAlindon TE, Bannuru RR, Sullivan MC et al (2014) OARSI guidelines for the non-surgical management of knee OA. Osteoarthr Cartil 22:363–388
Sakellariou G, Conaghan PG, Zhang W et al (2017) EULAR recommendations for the use of imaging in the clinical management of peripheral joint OA. Ann Rheum Dis 76:1484–1494
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.